共 154 条
[1]
Coiffier B(2002)CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma N Engl J Med 346 235-242
[2]
Lepage E(2017)Rituximab for severe membranous nephropathy: a 6-month trial with extended follow-up J Am Soc Nephrol 28 348-358
[3]
Briere J(2019)Rituximab or cyclosporine in the treatment of membranous nephropathy N Engl J Med 17 311-320
[4]
Herbrecht R(2017)Safety of rituximab compared with steroids and cyclophosphamide for idiopathic membranous nephropathy J Am Soc Nephrol 28 2729-2737
[5]
Tilly H(2014)Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial Lancet 384 1273-1281
[6]
Bouabdallah R(2018)Efficacy of rituximab vs tacrolimus in pediatric corticosteroid-dependent nephrotic syndrome: a randomized clinical trial JAMA Pediatr 172 757-764
[7]
Dahan K(2013)Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease Kidney Int 83 511-516
[8]
Debiec H(2016)Amelioration of the adverse effects of prednisolone by rituximab treatment in adults with steroid-dependent minimal-change nephrotic syndrome Clin Exp Nephrol 20 103-110
[9]
Plaisier E(2017)Rituximab treatment in adults with refractory minimal change disease or focal segmental glomerulosclerosis Oncotarget 8 93438-93443
[10]
Cachanado M(2013)Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults Nephrol Dial Transpl 28 1225-1232